Scholarlink

Background <p>Cardiovascular disease (CVD) remains the leading cause of death worldwide. While traditional risk factors are well-established, emerging evidence suggests shift work causing circadian rhythm disruption significantly contributes to CVD risk. This systematic review investigated molecular mechanisms linking circadian disruption with cardiovascular pathophysiology through in vivo models.</p> Methods <p>We systematically searched Medline, Embase, and Web of Science through February 2025. Studies employing genetic (clock gene knockouts/mutations) or environmental (light phase shift, sleep deprivation) models of circadian disruption in vivo were included. Meta-analyses were performed for key cardiovascular indicators, and certainty of evidence was evaluated using a modified GRADE approach.</p> Results <p>Among 9012 references, 34 studies met inclusion criteria. Following quality assessment for study design and reporting, 32 studies with low or moderate risk of bias were included in the synthesis. Meta-analyses revealed cardiac hypertrophy as the most robust finding, with high-certainty evidence for increased left ventricular mass-to-body weight ratio (LV/BW; SMD: 0.89, 95% CI: 0.38 to 1.39) and moderate-certainty evidence for increased cardiomyocyte size. These convergent organ and cellular-level findings, supported by elevated natriuretic peptides and pro-fibrotic markers, indicate circadian disruption contributes to pathological cardiac remodeling. Sensitivity analyses revealed low-certainty evidence for impaired systolic function, with significant reductions in ejection fraction (SMD: − 1.70, 95% CI: − 3.22 to − 0.17) and fractional shortening (SMD: − 1.60, 95% CI: − 2.71 to − 0.49). Low-certainty evidence was found for impaired endothelium-dependent vasorelaxation (SMD: − 2.72, 95% CI: − 4.90 to − 0.53) based on three genetic model studies with high heterogeneity and elevated triglyceride levels (SMD: 1.64, 95% CI: 0.07 to 3.21). Other markers showed very low-certainty evidence.</p> Conclusions <p>This systematic review improves mechanistic understanding of CVD development following circadian misalignment by demonstrating cardiac hypertrophy as a major pathophysiological consequence in animal models. Cardiac structural changes at organ and cellular levels, supported by biomarkers of pathological remodeling, indicate circadian disruption contributes to adverse cardiac remodeling. Future animal research should prioritize standardized protocols, sex-balanced designs, and environmental models replicating human shiftwork patterns. Substantial epidemiological gaps remain, warranting further investigation in shift workers.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Circadian rhythm disruption in cardiovascular disease: a systematic review and meta-analysis of mechanistic evidence from animal models

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月9日

查看全文
  • Mrinal K. Das,
  • Evi De Ryck,
  • Ingrid L. Jorgensen,
  • Shan Zienolddiny-Narui,
  • Johanna Samulin Erdem

摘要

Background

Cardiovascular disease (CVD) remains the leading cause of death worldwide. While traditional risk factors are well-established, emerging evidence suggests shift work causing circadian rhythm disruption significantly contributes to CVD risk. This systematic review investigated molecular mechanisms linking circadian disruption with cardiovascular pathophysiology through in vivo models.

Methods

We systematically searched Medline, Embase, and Web of Science through February 2025. Studies employing genetic (clock gene knockouts/mutations) or environmental (light phase shift, sleep deprivation) models of circadian disruption in vivo were included. Meta-analyses were performed for key cardiovascular indicators, and certainty of evidence was evaluated using a modified GRADE approach.

Results

Among 9012 references, 34 studies met inclusion criteria. Following quality assessment for study design and reporting, 32 studies with low or moderate risk of bias were included in the synthesis. Meta-analyses revealed cardiac hypertrophy as the most robust finding, with high-certainty evidence for increased left ventricular mass-to-body weight ratio (LV/BW; SMD: 0.89, 95% CI: 0.38 to 1.39) and moderate-certainty evidence for increased cardiomyocyte size. These convergent organ and cellular-level findings, supported by elevated natriuretic peptides and pro-fibrotic markers, indicate circadian disruption contributes to pathological cardiac remodeling. Sensitivity analyses revealed low-certainty evidence for impaired systolic function, with significant reductions in ejection fraction (SMD: − 1.70, 95% CI: − 3.22 to − 0.17) and fractional shortening (SMD: − 1.60, 95% CI: − 2.71 to − 0.49). Low-certainty evidence was found for impaired endothelium-dependent vasorelaxation (SMD: − 2.72, 95% CI: − 4.90 to − 0.53) based on three genetic model studies with high heterogeneity and elevated triglyceride levels (SMD: 1.64, 95% CI: 0.07 to 3.21). Other markers showed very low-certainty evidence.

Conclusions

This systematic review improves mechanistic understanding of CVD development following circadian misalignment by demonstrating cardiac hypertrophy as a major pathophysiological consequence in animal models. Cardiac structural changes at organ and cellular levels, supported by biomarkers of pathological remodeling, indicate circadian disruption contributes to adverse cardiac remodeling. Future animal research should prioritize standardized protocols, sex-balanced designs, and environmental models replicating human shiftwork patterns. Substantial epidemiological gaps remain, warranting further investigation in shift workers.

Graphical Abstract